Relationship Between LS Chirp ABR and Speech-in-Noise Skills in Hidden Hearing Loss

Recruiting Observational Study
Hidden Hearing Loss Cochlear Synaptopathy
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
20 – 60
Sex
Any
Study type
Observational
Participants needed
63 (estimated)
Sponsor
Istanbul University - Cerrahpasa · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
It is known that the underlying problem in Hidden Hearing Loss (HHL) is cochlear synaptopathy (CS) and that low-spontaneous-rate auditory nerve fibers play an important role in this pathology. Therefore, it is suggested that low-spontaneous-rate auditory nerve fibers are damaged in HHL. Consequently, LS CE-Chirp-evoked ABR and HINT, which assesses CS by presenting stimuli of varying intensities an…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria (Control group): * Being between 20 and 60 years of age, * Having bilateral pure-tone audiometry averages (500-1000-2000-4000 Hz) within the normal range (≤25 dB HL), * Having no tinnitus or auditory complaints, * Scoring 21 or above on the MoCA test, * Having no emotional or neu…
Contacts

Cem Yeral, MSc

+90 539 402 78 46

cem.yeral@ogr.iuc.edu.tr

CONTACT